Federal Register of Legislation - Australian Government

Primary content

PB 69 of 2012 Specifications as made
This instrument provides for the deletion of three entries; Etidronic Acid, Risedronic acid and calcium in the form Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate), and Verapamil in the form Tablet containing verapamil hydrochloride 160 mg.
Administered by: Health
Registered 22 Aug 2012
Tabling HistoryDate
Tabled HR23-Aug-2012
Tabled Senate23-Aug-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 69 of 2012

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment September 2012 - specification under subsection 84AAA(2)1

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated         15 August 2012

 

 

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment September 2012 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as No. PB 69 of 2012.


 

2          Commencement

 

This Instrument commences on 1 September 2012.

 

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.

 


Schedule 1        Amendments

[1]                       Schedule 1, omit entry for Etidronic Acid

 

[2]                       Schedule 1, entry for Risedronic acid and calcium

omit:

 

Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)

Oral

1

5

 

 

[3]                       Schedule 1, entry for Verapamil

omit:

 

Tablet containing verapamil hydrochloride 160 mg

Oral

60

5

 

 

 

 

 

 

 

 

 

 

 

 

1Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 

See http://www.frli.gov.au.